Thwarting PTEN Expression By SiRNA, Augments HL-60 Cell Differentiation To Neutrophil-like Cells By DMSO And ATRA And Reduces NETosis | 60076
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

2nd International Conference on Biotechnology and Healthcare

Auckland, New Zealand
Google scholar citation report
Citations : 1536

Journal of Biotechnology & Biomaterials received 1536 citations as per google scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Thwarting PTEN expression by siRNA, augments HL-60 cell differentiation to neutrophil-like cells by DMSO and ATRA and reduces NETosis

13th Biotechnology Congress

Shahram Teimourian

Iran University of Medical Sciences, Iran

ScientificTracks Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X.C1.067

Abnormal cell differentiation in particular suppression of terminal cell differentiation, exist in all tumors. Therapeutic intervention to restore terminal differentiation (differentiation therapy) is a very attractive way to treat cancer, especially leukemia. A variety of chemicals stimulates differentiation of leukemic cells such as dimethyl sulfoxide (DMSO) and all-trans retinoic acid (ATRA). Tumor suppressor genes have a vital role in the gateway to terminal cell differentiation. In this study we inhibited PTEN tumor suppressor gene expression by siRNA to investigate the effect of potentiating cell survival and inhibiting apoptosis on HL-60 cell differentiation by DMSO and ATRA at the same time we looked at NETosis. Our results show that PTEN siRNA increases HL-60 cell differentiation in the presence of DMSO and ATRA. At the same time the presence of siRNA hampered accumulation of apoptotic cells during incubation. PTEN siRNA reduced Net formation by differentiated neutrophils. Our study suggests potential usage of differentiation therapy in PTEN mutated AML leukemia.

Shaharm Teimourian has completed his PhD from Tehran University and Postdoctoral studies from Oxford University School of Medicine. He is the Director of Medical Genetics and Biotechnology Department. He has published more than 25 papers in reputed journals and has been serving as an Editorial Board Member of Edorium™ Journal of Molecular Biology and World Journal of Hematology.

Email: [email protected]